Adrenergic Gate Release for Spike Timing-Dependent Synaptic Potentiation
Overview
Affiliations
Spike timing-dependent synaptic plasticity (STDP) serves as a key cellular correlate of associative learning, which is facilitated by elevated attentional and emotional states involving activation of adrenergic signaling. At cellular levels, adrenergic signaling increases dendrite excitability, but the underlying mechanisms remain elusive. Here we show that activation of β2-adrenoceptors promoted STD long-term synaptic potentiation at mouse hippocampal excitatory synapses by inactivating dendritic Kv1.1-containing potassium channels, which increased dendrite excitability and facilitated dendritic propagation of postsynaptic depolarization, potentially improving coincidental activation of pre- and postsynaptic terminals. We further demonstrate that adrenergic modulation of Kv1.1 was mediated by the signaling scaffold SAP97, which, through direct protein-protein interactions, escorts β2 signaling to remove Kv1.1 from the dendrite surface. These results reveal a mechanism through which the postsynaptic signaling scaffolds bridge the aroused brain state to promote induction of synaptic plasticity and potentially to enhance spike timing and memory encoding.
β-adrenergic receptor-induced E-S potentiation in the dorsal and ventral hippocampus.
Trompoukis G, Miliou A, Papatheodoropoulos C Front Synaptic Neurosci. 2025; 16:1511485.
PMID: 39758826 PMC: 11695307. DOI: 10.3389/fnsyn.2024.1511485.
Hippocampal contextualization of social rewards in mice.
Duarte J, Nguyen R, Kyprou M, Li K, Milentijevic A, Cerquetella C Nat Commun. 2024; 15(1):9493.
PMID: 39489746 PMC: 11532361. DOI: 10.1038/s41467-024-53866-2.
Neuronal activity in the human amygdala and hippocampus enhances emotional memory encoding.
Qasim S, Mohan U, Stein J, Jacobs J Nat Hum Behav. 2023; 7(5):754-764.
PMID: 36646837 PMC: 11243592. DOI: 10.1038/s41562-022-01502-8.
Tsetsenis T, Badyna J, Li R, Dani J Front Cell Neurosci. 2022; 16:887679.
PMID: 35496910 PMC: 9051520. DOI: 10.3389/fncel.2022.887679.
Griesius S, ODonnell C, Waldron S, Thomas K, Dwyer D, Wilkinson L Neuropsychopharmacology. 2022; 47(7):1367-1378.
PMID: 35115661 PMC: 9117295. DOI: 10.1038/s41386-022-01277-6.